药明康德：前三季度归母净利润增长84.84%

Core Insights - WuXi AppTec reported a net profit of 3.515 billion yuan for Q3, representing a year-on-year increase of 53.27% [1] - For the first three quarters, the net profit reached 12.076 billion yuan, showing a year-on-year growth of 84.84% [1] - The company continues to focus on and strengthen its CRDMO business model, leading to sustained revenue growth [1] Financial Performance - The net profit for Q3 was 3.515 billion yuan, up 53.27% compared to the same period last year [1] - The net profit for the first three quarters totaled 12.076 billion yuan, reflecting an 84.84% increase year-on-year [1] Business Strategy - The company is optimizing production processes and operational efficiency, contributing to improved overall profitability [1] - Growth in late-stage clinical and commercialization projects has enhanced capacity efficiency [1] - The sale of part of its stake in the joint venture WuXi XDC Cayman Inc. has further boosted the company's profits [1]